Skip to content

Treatment of recurrent urinary tract infection

Comparative study of effectiveness of long term low dose antibiotic Prophylaxis in patients with recurrent UTI

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201112095641N2
Enrollment
100
Registered
2011-12-15
Start date
2012-01-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Tract Infection. Urinary tract infection, site not specified

Interventions

After properly treating the current UTI, we will start longterm lowdose antibiotic (Coterimoxazole or Nalidixic acid) based on urine culture and antibiogram. One tablet per night for adults and weight
Treatment - Drugs

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Any patient with recurrent Urinary Tract Infection, at least 3 episode of UTI during past 12 months. Exclusion criteria: Abnormal finding in physical examination or in paraclinic (ultrasonography, VCUG, Isotope Scan, IVP)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
No Urinary Tract Infection. Timepoint: Every month for 2 months and then every 2 months for 10 months. Method of measurement: Urine Culture.

Secondary

MeasureTime frame
Recurence of Urinary Tract Infection. Timepoint: Every month for 2 months and then every 2 months for 10 months. Method of measurement: Urine Culture.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSeyed Habibollah Mousavi-bahar

Hamedan University of Medical sciences

shmbahar@umsha.ac.ir , shmbahar@yahoo.com+98 81 1823 0829

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026